Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
Gix,
What does the patent ‘ Improved Fruitflow / Fruit Extracts’ cover. What is the ‘Fruit Extracts’ part of it? Not sure I understand the scope of what is covered.
And it's in stock :)
It's definitely a new one. I've never seen that before. Good find.
We don't know that it is anything to do with that. I could have sold better than expected, so out of stock. It could have sold worse than expecting, so they are not bothering restocking and will be removing it. Perhaps they just bought a single batch on a deal and will now evaluate whether to restock.
You can't really read anything into an item being out of stock. If you go to a website and the shoes you want are not available, does it always mean there is a problem with the shoe producer? Not at all.
If it wasn't out of stock that is :)
Not sure how long Brickerlabs has been available in Walmart, but always nice to see.
https://www.walmart.com/ip/OptiFlow-Naturally-Supports-Healthy-Blood-Circulation-with-FruitFlow-and-resVida/960646018
Whilst they are low on funds they will avoid putting out RNS unless they have to. Years ago we asked Moon about getting more regular updates and he said it cost about £5k for an RNS. That was in about 2011. IF must believe that this does not warrant an RNS under the regulations and wants to keep costs low.
Which you already shared :)
It has its own site
https://zaax.com.pl/
Yeh, I found it elsewhere. I used Google images to search for that image.
Have we seen it before? I forget.
The people selling are based in Taiwan it seems.
Anyone seen this one before?
https://www.facebook.com/photo?fbid=642391017893694&set=pcb.642393331226796
Not sure what it is, but it has FF.
The cost will reduce lots further when the volume increases too :)
IF will find communication easier now. Previously the company had 1 partner, DSM. Everything PXS wrote could potentially be tied to DSM and may be sensitive. They could not tell us FF revenue figures, as that belonged to DSM.
Things have changed, they now have a truck load of their own customers and PXS statements cannot easily be associated with a particular customer. They can report on current revenue, profits vs forecasted revenue and profits.
It’s all guess work, but that’s part of investing, thinking about what it means, what direction it’s going and whether your money should be invested there or not.
I am feeling very optimistic at present, but find the waiting difficult. I just want to know how wrong I am now without the wait.
I have stated my guess previously.
I would guess that the company would not aim to have more that 1 years worth of stock sitting around. The stock has a long shelf life and they may save money by producing higher volumes in one go, but I think 1 year is probably sensible for the remaining stock. It's pure speculation based on a feeling of what seems right to me.
All revenues will now come to PXS and PXS will pay DSM a fee for their customers. PXS will now be getting new customers outside this agreement, as per RNS. Also, DSM may be ordering from PXS now for their remaining customers, the ones that purchase premixes or off-the-shelf products. This will be at a much better rate for PXS.
Given the high price of PXS, the stock levels, the amount of customers etc, I would think that the total sales revenue would be somewhere around £5m. I have nothing to back this up with. I'm thinking £3m to £7m, probably £5m.
I would think the step-down would be something like:
Financial Year 1 - 80% to DSM, 20% to PXS
Financial Year 2 - 60% to DSM, 40% to PXS
Financial Year 3 - 40% to DSM, 60% to PXS
Financial Year 4 - 20% to DSM, 80% to PXS
Financial Year 5 - 0% to DSM, 100% to PXS
Therefore, Q4 of this financial year will be in step down 1
Next financial year will be 3/4 step 1, 1/4 step 2..... and so on.
Follow the logic?
We have no idea whether the numbers are correct, they are made up after all, but if you can speculate any better, then we'd all be interested in your numbers and rationale.
*DSM :)
Krusty,
As of Jan 01st this year, Provexis produce and sell ALL fruit flow. All revenues will go to Provexis. Almost all existing DSM customers have now transferred to Provexis. Provexis total revenue will now be up significantly. Provexis will now pay DMS a royalty fee for those customers, stepping down in amount each year over the next 4 years. That leads us to believe that we may enter profit this financial year, but if not, certainly next financial year, irrespective of BH, gut health and other things.
I would write some further information, but think the have maybe not read the RNS' and fully understood what is happening here.
Krusty,
In September last year, they predicted that there would be over €1m of stock remaining at year end. So after 3 months of further operations there will be €1m of stock remaining to transfer to PXS.
We now know that it now costs approximately €150 per KG to produce (down from €600).
So what you are saying Krusty is that when PXS buy €1m of stock at €150 per KG (6666.6 KG), then sell it for €900 per KG?? (€6m) then there will be no profit in that. How do you square that away?
We don't have any idea how long that stock will last, but I would think 1 year would be a reasonable guess as any.